Literature DB >> 9603426

Gscl, a gene within the minimal DiGeorge critical region, is expressed in primordial germ cells and the developing pons.

N Galili1, J A Epstein, I Leconte, S Nayak, C A Buck.   

Abstract

Gscl, a paired-type homeobox gene, has been implicated in the pathology of DGS/VCFS by virtue of its genomic location and its structural similarity to the Gsc gene family. Immunohistochemical and in situ studies were performed to examine the expression pattern of this gene during embryonic development. A polyclonal antibody, generated to the full-length protein and shown to be specific for GSCL by both Western blotting and immunofluorescence, was used for immunohistochemical localization. Both in situ and antibody staining localized GSCL expression to a cluster of cells in the pons region of the developing brain. This GSCL expression pattern showed partial overlap with that of Pax6. More detailed immunohistochemistry revealed the GSCL in primordial germ cells during migration from the epithelium of the hindgut and later as they colonize the developing gonads. GSCL was not detected in tissues affected in DGS/VCSF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603426     DOI: 10.1002/(SICI)1097-0177(199805)212:1<86::AID-AJA8>3.0.CO;2-Z

Source DB:  PubMed          Journal:  Dev Dyn        ISSN: 1058-8388            Impact factor:   3.780


  2 in total

1.  Developmental Requirement of Homeoprotein Otx2 for Specific Habenulo-Interpeduncular Subcircuits.

Authors:  Nuria Ruiz-Reig; Malalaniaina Rakotobe; Ingrid Bethus; Gwenaëlle Le Menn; Hannah-Isadora Huditz; Hélène Marie; Thomas Lamonerie; Fabien D'Autréaux
Journal:  J Neurosci       Date:  2018-12-28       Impact factor: 6.167

2.  Behavior of mice with mutations in the conserved region deleted in velocardiofacial/DiGeorge syndrome.

Authors:  Jeffrey M Long; Patricia LaPorte; Sandra Merscher; Birgit Funke; Bruno Saint-Jore; Anne Puech; Raju Kucherlapati; Bernice E Morrow; Arthur I Skoultchi; Anthony Wynshaw-Boris
Journal:  Neurogenetics       Date:  2006-08-10       Impact factor: 3.017

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.